Filing Details

Accession Number:
0000014272-21-000130
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-07 13:00:00
Reporting Period:
2021-05-05
Accepted Time:
2021-05-07 16:57:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744507 Adam Dubow Bristol-Myers Squibb Company
430 E. 29Th Street, 14 Floor
New York NY 10016
Svp,Chiefcompliance&Ethicsoff. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2021-05-05 3,119 $64.21 16,243 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.10 Par Value 965 Indirect By BMY Savings and Investment Program
Footnotes
  1. The price reported reflects the weighted average sales price. The shares were sold in two transactions at prices $64.21 and $64.215, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  2. Based on a plan statement as of the end of the most recent fiscal quarter.